Search NASA⌕ Search

SEARCH · Search NASA

Results for “LEAD COMPOUNDS”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 163 records · Page 9

Experimental and theoretical studies of Sn{sub 3-{delta}}Pb{sub {delta}}Bi{sub 2}Se{sub 6} (delta=0.0-0.7)

New ternary and quaternary chalcogenides, Sn{sub 3-{delta}}Pb{sub {delta}}Bi{sub 2}Se{sub 6} (delta=0.0-0.7), were synthesized from pure elements using the solid-state method. Their crystal structures, determined using single crystal X-ray diffraction, belong to the orthorhombic space group Pnma (No. 62). The structure is related to Pb{sub 3}Bi{sub 2}S{sub 6}, which contains NaCl [311] layer units and zigzag arrays of metal atoms along the c-axis. A correlation between the Pb composition and the shifted position of a metal site was observed. Band structure calculations confirmed that the structure is stabilized when the position of the M5 site is farther from the mirror plane. Thermopower and conductivity measurements indicated that all of the compounds are n-type semiconductors with small band gaps. - Graphical abstract: New ternary and quaternary chalcogenides, Sn{sub 3-{delta}}Pb{sub {delta}}Bi{sub 2}Se{sub 6} (delta=0.0-0.7), were synthesized and their structures are related to that of Pb{sub 3}Bi{sub 2}S{sub 6} with an atomic position near the cell-twinning plane. Band structure calculations confirmed that the structure is stabilized when the position of the M5 site is farther from the cell-twinning plane. All compounds are n-type semiconductors with small band gaps.

36 MATERIALS SCIENCE↗

The interplay of microstructure and magnetism in La{sub 3}Ni{sub 2}SbO{sub 9}

La{sub 3}Ni{sub 2}SbO{sub 9} adopts a perovskite-related structure in which the six-coordinate cation sites are occupied alternately by Ni{sup 2+} and a disordered arrangement of Ni{sup 2+}/Sb{sup 5+}. A polycrystalline sample has been studied by neutron diffraction in applied magnetic fields of 0≤H/kOe≤50 at 5 K. In 0 kOe, weak magnetic Bragg scattering consistent with the adoption of a G-type ferrimagnetic structure is observed; the ordered component of the magnetic moment was found to be 0.89(7) µ{sub B} per Ni{sup 2+} cation. This increased to 1.60(3) µ{sub B} in a field of 50 kOe. Transmission electron microscopy revealed variations in the Ni:Sb ratio across crystallites of the sample. It is proposed that these composition variations disrupt the magnetic superexchange interactions within the compound, leading to domain formation and a reduced average moment. The application of a magnetic field aligns the magnetisation vectors across the crystal and the average moment measured by neutron diffraction increases accordingly. The role played by variations in the local chemical composition in determining the magnetic properties invites comparison with the behaviour of relaxor ferroelectrics. - Graphical abstract: Composition variations across a crystal of La3Ni2SbO9 result in anomalous magnetic behavior. - Highlights: • Ordered magnetic moment of Ni{sup 2+} increases in an applied magnetic field. • Composition variations detected by electron microscopy. • Increase in magnetic moment can be explained by presence of composition variations.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Utilizing maleic acid as a novel fuel for synthesis of PbFe{sub 12}O{sub 19} nanoceramics via sol–gel auto-combustion route

PbFe{sub 12}O{sub 19} nanostructures were prepared in an aqueous solution by the sol–gel auto-combustion method using Pb(NO{sub 3}){sub 2} and Fe(NO{sub 3}){sub 3} as starting materials and various carboxylic acids, including oxalic acid, malonic acid, succinic acid and maleic acid as fuel and reducing and capping agents. The as-synthesized products were characterized by X- ray diffraction, scanning electron microscopy, and X-ray energy dispersive spectroscopy. The effect of carboxylic acid type, Pb{sup +} {sup 2} to carboxylic acid molar ratio, and calcination temperature was investigated on the morphology of the products and several experiments were carried out to obtain the optimal reaction conditions. It was found that the phase and the morphology of the products are influenced by the investigated parameters. Furthermore, vibrating sample magnetometer (VSM) was used to study the magnetic properties of PbFe{sub 12}O{sub 19} samples. - Graphical abstract: Display Omitted - Highlights: • PbFe{sub 12}O{sub 19} nanoceramics were synthesized from Fe(NO{sub 3}){sub 3} and Pb(NO{sub 3}){sub 2} via the sol–gel auto combustion method. • The maleic acid can be instead of common capping agent and fuel in auto-combustion sol–gel. • The synthesized PbFe{sub 12}O{sub 19} is a hard magnetic material. • The specific saturation magnetization and coercivity are 27 emu/g and 1900 Oe, respectively.

77 NANOSCIENCE AND NANOTECHNOLOGY↗

Structural phase transitions of ionic layered PbFX (X = Cl{sup −}or Br{sup –}) compounds under high pressure

The PbFX (X = Cl{sup –}or Br{sup –}) compounds crystallize in tetragonal structure with space group P4/nmm. High pressure X-ray diffraction studies carried out on PbFCl compound reveals that it undergoes pressure induced structural transitions at ∼18 GPa and ∼38 GPa to orthorhombic and monoclinic (P2{sub 1}/m) phases respectively. Like PbFCl, a similar phase transition from tetragonal to orthorhombic phase is observed in PbFBr at intermediate pressure. These phase transitions seem to be similar to the transitions involving other matlockite structure compounds such as BaFX (X = Cl{sup –}, Br{sup –}or I{sup –}). PbFCl has a larger structural stability range compared to BaFCl and is attributed to the large anisotropic coordination of the Pb{sup 2+} and Cl{sup –}ions.

75 CONDENSED MATTER PHYSICS, SUPERCONDUCTIVITY AND↗

BFD-22 a new potential inhibitor of BRAF inhibits the metastasis of B16F10 melanoma cells and simultaneously increased the tumor immunogenicity

Benzofuroxan is an interesting ring system, which has shown a wide spectrum of biological responses against tumor cell lines. We investigated, herein, the antitumor effects of benzofuroxan derivatives (BFDs) in vitro and in a melanoma mouse model. Cytotoxic effects of twenty-two BFDs were determined by MTT assay. Effects of BFD-22 in apoptosis and cell proliferation were evaluated using Annexin V-FITC/PI and CFSE staining. In addition, the effects in the cell cycle were assessed. Flow cytometry, western blot, and fluorescence microscopy analysis were employed to investigate the apoptosis-related proteins and the BRAF signaling. Cell motility was also exploited through cell invasion and migration assays. Molecular docking approach was performed in order to verify the BFD-22 binding mode into the ATP catalytic site of BRAF kinase. Moreover, the BFD-22 antitumor effects were evaluated in a melanoma murine model using B16F10. BFD-22 was identified as a potential hit against melanoma cells. BFD-22 induced apoptosis and inhibited cell proliferation of B16F10 cells. BFD-22 has suppressed, indeed, the migratory and invasive behavior of B16F10 cells. Cyclin D1 and CDK4 expression were reduced leading to cell cycle arrest at G0/G1 phase. Of note, phosphorylation of BRAF at Ser338 was strongly down-regulated by BFD-22 in B16F10 cells. The accommodation/orientation into the binding site of BRAF was similar of BAY43-9006 (co-crystallized inhibitor of BRAF, sorafenib). Importantly, BFD-22 presented in vivo antimetastatic effects and showed better therapeutic efficacy than sorafenib and taxol. BFD-22 can be considered as a new lead compound and, then, can be helpful for the designing of novel drug candidates to treat melanoma. - Highlights: • BFD-22 induces apoptosis effects of B16F10 cells by mitochondrial pathway. • BFD-22 provokes downstream in the MAPK/ERK kinase signaling cascade. • Molecular docking trials supported BRAF protein as potential target for BDF-22. • BFD-22 increases the therapeutic tumor immunogenicity. • BFD-22 presents stronger in vivo anti-metastatic effects than sorafenib and taxol.

60 APPLIED LIFE SCIENCES↗

Curcumin rescues high fat diet-induced obesity and insulin sensitivity in mice through regulating SREBP pathway

Obesity and its major co-morbidity, type 2 diabetes, have reached an alarming epidemic prevalence without an effective treatment available. It has been demonstrated that inhibition of SREBP pathway may be a useful strategy to treat obesity with type 2 diabetes. Sterol regulatory element-binding proteins (SREBPs) are major transcription factors regulating the expression of genes involved in biosynthesis of cholesterol, fatty acid and triglyceride. In current study, we identified a small molecule, curcumin, inhibited the SREBP expression in vitro. The inhibition of SREBP by curcumin decreased the biosynthesis of cholesterol and fatty acid. In vivo, curcumin ameliorated HFD-induced body weight gain and fat accumulation in liver or adipose tissues, and improved serum lipid levels and insulin sensitivity in HFD-induced obese mice. Consistently, curcumin regulates SREBPs target genes and metabolism associated genes in liver or adipose tissues, which may directly contribute to the lower lipid level and improvement of insulin resistance. Take together, curcumin, a major active component of Curcuma longa could be a potential leading compound for development of drugs for the prevention of obesity and insulin resistance. - Highlights: • Curcumin decreases biosynthesis of cholesterol and fatty acid in vitro. • Curcumin as a SREBP inhibitor ameliorates HFD-induced obesity. • Curcumin as a SREBP inhibitor improves insulin resistance.

60 APPLIED LIFE SCIENCES↗

Magnetic instability in Ce heavy fermion compounds

Different types of cerium heavy fermion compounds are discussed: cubic antiferromagnetic ground states (CeAl 2 , CePb 3 , Celn 3 ) and Pauli paramagnetic ground states (CeSn 3 , CeRu 2 Si 2 ). Applying external variables such as pressure or magnetic field restores a localized Fermi liquid state. Special attention is paid to CeRu 2 Si 2 which is approaching a singular magnetic instability for T→ 0. Comparison between pressure and alloying effects emphasize the important role of the itineracy of the 4f electrons at the magnetic instability.

36 MATERIALS SCIENCE↗

Radiation Effects on Uranyl Tetrachloro Coordination Compounds: Impact of Lattice Water

Nuclear materials, such as uranium-bearing solids, are exposed to high levels of ionizing radiation throughout the nuclear fuel cycle; thus, it is important to develop a molecular-level understanding of how these materials behave and degrade in the presence of gamma (γ) irradiation. In the current study, three U(VI) tetrachloride complexes, M 2 [UO 2 Cl 4 ]·xH 2 O (where M = K + , Rb + , or Cs + and x = 0 or 2), and their respective chloride salts were exposed to 1–50 kGy of γ radiation using a 60 Co source. Irradiated materials were evaluated by using electron paramagnetic resonance (EPR) and Raman spectroscopy and were further explored by using density functional theory (DFT) methods. EPR spectra of the irradiated materials suggest the formation of a Cl-based radical for both the alkali salts and the uranyl tetrachloride compounds, and DFT calculations provide evidence that the Cl 2 –• radical is formed within these materials. The presence of water in the K + and Rb + compounds leads to additional spectroscopic signatures that could be traced back to water radiolysis and the formation of peroxide and superoxide species. DFT results support the formation of HO 2 • in the lattice and potentially the formation of a [UO 2 Cl 3 (O 2 )] 3– species, highlighting the impact of water within the hydrated material to alter U(VI) speciation by radiolysis.

36 MATERIALS SCIENCE↗

Fragment-based discovery of a small molecule inhibitor of Bruton’s Tyrosine Kinase

The discovery and optimization of a series of 4-aminocinnoline-3-carboxamide inhibitors of Bruton’s tyrosine kinase are reported. A fragment-based screening approach incorporating X-ray co-crystallography was used to identify a cinnoline fragment and characterize its binding mode in the ATP binding site of Btk. Optimization of the fragment hit resulted in the identification of a lead compound which reduced paw swelling in a dose- and exposure-dependent fashion in a rat model of collagen-induced arthritis.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Discovery of 2-Pyridinone Aminals: A Prodrug Strategy to Advance a Second Generation of HIV-1 Integrase Strand Transfer Inhibitors

The search for new molecular constructs that resemble the critical two-metal binding pharmacophore required for HIV integrase strand transfer inhibition represents a vibrant area of research within drug discovery. Here we present the discovery of a new class of HIV integrase strand transfer inhibitors based on the 2-pyridinone core of MK-0536. These efforts led to the identification of two lead compounds with excellent antiviral activity and preclinical pharmacokinetic profiles to support a once-daily human dose prediction. Dose escalating PK studies in dog revealed significant issues with limited oral absorption and required an innovative prodrug strategy to enhance the high-dose plasma exposures of the parent molecules.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Optimization of Species-Selective Reversible Proteasome Inhibitors for the Treatment of Malaria

Abstract Malaria remains a critical global health challenge, with increasing resistance to frontline therapies necessitating novel drug targets. The proteasome has emerged as a promising target for antimalarial drug discovery. This study describes efforts to optimize a series of species-selective reversible inhibitors targeting the Plasmodium falciparum 20S proteasome. Starting from the carboxypiperidine scaffold identified through a high-throughput viability screen, we conducted iterative structure–activity relationship studies, leading to the development of highly potent and selective inhibitors with good oral bioavailability. Lead compounds demonstrated nanomolar potency against P. falciparum blood-stage parasites and selective inhibition of the parasite proteasome over the human counterpart. Cryo-EM structural studies confirmed binding at the β5 subunit, while in vivo pharmacokinetic studies identified promising candidates for further development. These findings support proteasome inhibition as a viable strategy for novel antimalarial drug development.

Gahalawat, Suraksha [UT Southwestern Medical Cente↗

Discovery and Preclinical Characterization of 6-Chloro-5-[4-(1-hydroxycyclobutyl)phenyl]-1 H -indole-3-carboxylic Acid (PF-06409577), a Direct Activator of Adenosine Monophosphate-activated Protein Kinase (AMPK), for the Potential Treatment of Diabetic Nephropathy

Adenosine monophosphate-activated protein kinase (AMPK) is a protein kinase involved in maintaining energy homeostasis within cells. On the basis of human genetic association data, AMPK activators were pursued for the treatment of diabetic nephropathy. Identification of an indazole amide high throughput screening (HTS) hit followed by truncation to its minimal pharmacophore provided an indazole acid lead compound. Optimization of the core and aryl appendage improved oral absorption and culminated in the identification of indole acid, PF-06409577 (7). Compound 7 was advanced to first-in-human trials for the treatment of diabetic nephropathy.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Discovery of Potent 2-Aryl-6,7-dihydro-5$H$-pyrrolo[1,2-$a$]imidazoles as WDR5-WIN-Site Inhibitors Using Fragment-Based Methods and Structure-Based Design

WDR5 is a chromatin-regulatory scaffold protein overexpressed in various cancers and a potential epigenetic drug target for the treatment of mixed-lineage leukemia. In this a paper, we describe the discovery of potent and selective WDR5-WINsite inhibitors using fragment-based methods and structure-based design. NMR-based screening of a large fragment library identified several chemically distinct hit series that bind to the WIN site within WDR5. Members of a 6,7-dihydro-5$H$pyrrolo[1,2-$a$]imidazole fragment class were expanded using a structure-based design approach to arrive at lead compounds with dissociation constants <10 nM and micromolar cellular activity against an AML-leukemia cell line. These compounds represent starting points for the discovery of clinically useful WDR5 inhibitors for the treatment of cancer.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Targeting the BACE1 Active Site Flap Leads to a Potent Inhibitor That Elicits Robust Brain Aβ Reduction in Rodents

By targeting the flap backbone of the BACE1 active site, we discovered 6-dimethylisoxazole-substituted biaryl aminothiazine 18 with 34-fold improved BACE1 inhibitory activity over the lead compound 1. The cocrystal structure of 18 bound to the active site indicated two hydrogen-bond interactions between the dimethylisoxazole and threonine 72 and glutamine 73 of the flap. Incorporation of the dimethylisoxazole substitution onto the related aminothiazine carboxamide series led to pyrazine-carboxamide 26 as a very potent BACE1 inhibitor (IC 50 < 1 nM). This compound demonstrated robust brain Aβ reduction in rat dose–response studies. Thus, compound 26 may be useful in testing the amyloid hypothesis of Alzheimer’s disease.

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design

In an effort to develop a novel therapeutic agent aimed at addressing the unmet need of patients with osteoarthritis pain, we set out to develop an inhibitor for autotaxin with excellent potency and physical properties to allow for the clinical investigation of autotaxin-induced nociceptive and neuropathic pain. An initial hit identification campaign led to an aminopyrimidine series with an autotaxin IC 50 of 500 nM. X-ray crystallography enabled the optimization to a lead compound that demonstrated favorable potency (IC 50 = 2 nM), PK properties, and a robust PK/PD relationship.

60 APPLIED LIFE SCIENCES↗

Design, Synthesis, and Characterization of Novel Small Molecules as Broad Range Antischistosomal Agents

Schistosomiasis is a major human parasitic disease afflicting more than 250 million people, historically treated with chemotherapies praziquantel or oxamniquine. Since oxamniquine is species-specific, killing Schistosoma mansoni but not other schistosome species ( S. haematobium or S. japonicum ) and evidence for drug resistant strains is growing, research efforts have focused on identifying novel approaches. Guided by data from X-ray crystallographic studies and Schistosoma worm killing assays on oxamniquine, our structure-based drug design approach produced a robust structure–activity relationship (SAR) program that identified several new lead compounds with effective worm killing. We report these studies culminated in the discovery of compound 12a , which demonstrated broad-species activity in killing S. mansoni (75%), S. haematobium (40%), and S. japonicum (83%).

37 INORGANIC, ORGANIC, PHYSICAL, AND ANALYTICAL CH↗

Discovery of Potent Myeloid Cell Leukemia 1 (Mcl-1) Inhibitors Using Fragment-Based Methods and Structure-Based Design

Myeloid cell leukemia 1 (Mcl-1), a member of the Bcl-2 family of proteins, is overexpressed and amplified in various cancers and promotes the aberrant survival of tumor cells that otherwise would undergo apoptosis. Here we describe the discovery of potent and selective Mcl-1 inhibitors using fragment-based methods and structure-based design. NMR-based screening of a large fragment library identified two chemically distinct hit series that bind to different sites on Mcl-1. Members of the two fragment classes were merged together to produce lead compounds that bind to Mcl-1 with a dissociation constant of <100 nM with selectivity for Mcl-1 over Bcl-xL and Bcl-2. Structures of merged compounds when complexed to Mcl-1 were obtained by X-ray crystallography and provide detailed information about the molecular recognition of small-molecule ligands binding Mcl-1. The compounds represent starting points for the discovery of clinically useful Mcl-1 inhibitors for the treatment of a wide variety of cancers.

Friberg, Anders↗

Development of human cGAS-specific small-molecule inhibitors for repression of dsDNA-triggered interferon expression

Cyclic GMP-AMP synthase (cGAS) is the primary sensor for aberrant intracellular dsDNA producing the cyclic dinucleotide cGAMP, a second messenger initiating cytokine production in subsets of myeloid lineage cell types. Therefore, inhibition of the enzyme cGAS may act anti-inflammatory. Here we report the discovery of human-cGAS-specific small-molecule inhibitors by high-throughput screening and the targeted medicinal chemistry optimization for two molecular scaffolds. Lead compounds from one scaffold co-crystallize with human cGAS and occupy the ATP- and GTP-binding active site. The specificity and potency of these drug candidates is further documented in human myeloid cells including primary macrophages. These novel cGAS inhibitors with cell-based activity will serve as probes into cGAS-dependent innate immune pathways and warrant future pharmacological studies for treatment of cGAS-dependent inflammatory diseases.

59 BASIC BIOLOGICAL SCIENCES↗